Navigation Links
BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting
Date:5/15/2009

tients, 58% for all Stage IV patients and 48% for Stage IV M1c patients. The 1-year survival of the patients who achieved PR, CR or surgical CR (n=15) was 93% compared to 48% for those with stable or progressive disease.

Commenting on these results, Dr. Neil N. Senzer of The Mary Crowley Cancer Research Center in Dallas, TX, the lead author for the presentation, said:

"Compared to any historical benchmarks for patients with Stage IIIc and Stage IV melanoma, this survival data, especially when coupled with a low toxicity profile, is provocative. Additionally, of the responses previously reported the vast majority have been maintained for up to more than three years from enrollment. I look forward to the results of the subsequent Phase III study which has recently initiated."

OPTiM Phase III Trial

The trial is a multi-national, open label, randomized Phase 3 study to assess the efficacy and safety of treatment with OncoVEX GM-CSF as compared to sub cutaneously administered GM-CSF in patients with unresectable stage III (b-c) and Stage IV (M1a-c) disease. The primary endpoint is the rate of durable (maintained for six months) objective response. Patients will have received at least one prior therapy for active disease which includes any type of therapy including investigational drugs. A total of 360 patients will be enrolled (240 to the OncoVEX GM-CSF arm and 120 to the control arm). The study design was agreed with the FDA under the Special Protocol Assessment ("SPA") process. The SPA process provides for a designation from the FDA that the trial's design, clinical endpoints and statistical analysis can be used for regulatory approval.

About Metastatic Melanoma

According to the American Cancer Society, more than 8,000 people died in the U.S. of me
'/>"/>

SOURCE BioVex Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
11. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Wolters Kluwer , a ... students, announced today that in a survey of nearly ... of the clinical decision support resource improves the quality ... 2014, UpToDate users in more than 170 countries worldwide ... on average. In Germany alone, 95% of all university ...
(Date:5/6/2015)... 06, 2015 Healthcare jobs ... after launching in mid-February. The company connects hospitals, home-health, ... previous experience in the industry. Likewise, job seekers are ... to Kyle Johnson, CTO, unique traffic to the site ... month: "Each new job posting brings targeted, interested candidates ...
(Date:5/6/2015)... Locally owned, Greek olive oil producer and importer, Our Family’s ... one the best Extra Virgin Olive Oils in the world. ... Greece and known as Laconiko , received the ... Oil, which is defined by the competition as “the perfect ... applicants from 25 different countries applying, Laconiko stood out as ...
(Date:5/6/2015)... 06, 2015 Dr. Vito C. Quatela, one ... , recently completed a medical mission trip to Hanoi, Vietnam ... those affected by microtia and other deformities of the face. ... and ended on April 26, Dr. Quatela and his team ... a congenital deformity where the outside of the ear is ...
(Date:5/6/2015)... Los Angeles, California (PRWEB) May 06, 2015 ... has secured its first round of VC funding and ... , The enterprise class embeddable software enables applications ... transform data as it moves between systems and locations. ... the HyperTransfer technology moves files at line speed, independent ...
Breaking Medicine News(10 mins):Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:Greek Extra Virgin Olive Oil, Laconiko Wins Gold at the NYIOOC and Is Featured in Olive Oil Times as One of Greece's Best EVOO's for 2015 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 3Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 2Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 3Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 4
... New study says that how much we drink may be ... revealed that the gene called DRD2 Taq1A(C32806T) polymorphism and social ... people with a stronger gene of this type will tend ... of this gene. The gene is responsible for enhancing the ...
... study, the drug perindopril used in early treatment of ... onset and progress of left ventricle dysfunction. ... muscular dystrophies that are characterized by muscle enlargement and ... is linked with the X-chromosomes and thus affects male ...
... A research which examined the tobacco byproducts in the ... been fooling // themselves by thinking that they are ... cigarettes. ,No significant difference was found in ... regardless of the type of cigarettes they smoked nor ...
... recent study in the journal Health and Place says that mercury ... of the reasons // of rise in number of autistic children. ... of the power plants that consume coal. According to the researchers, ... into the environment, there is a 61% increase in the rate ...
... E seemed to suggest that supplementing the diet with ... //Recently, a study published In Journal Of American Medical ... may be something very different. ,The researchers ... Prevention Evaluation or HOPE centers between 1993 and 1999, ...
... the apex medical body warns the people of South East ... bird flu virus in the area. It has also ... information to WHO regarding new cases of the disease. The ... closeness in occurrence in time and place is important to ...
Cached Medicine News:
(Date:5/6/2015)... 2015 Woodford Patient Capital ... Trust and the Bill & Melinda Gates Foundation ... a leading monoclonal antibody biopharmaceutical company, announced today ... million to complete a US$90 million Series B ... Woodford Patient Capital Trust plc (LSE:WPCT,"Woodford") and Malin ...
(Date:5/5/2015)... , May 6, 2015 The ... lead the European market in the segment of animal ... alliance ECUPHAR acquires all the assets of Esteve Veterinary ... in the coming weeks. Being both private companies, the ...      (Photo: http://photos.prnewswire.com/prnh/20150506/743274 ) , ...
(Date:5/5/2015)... , May 5, 2015  In line with CBME ... to the community with a charity program to create ... autism. CBME China team is coordinating ... and maternity manufacturers, brand owners and distributors. All donated ... July 2015. Proceeds from the sale will be used ...
Breaking Medicine Technology:Kymab Secures US$90 Million Funding 2Kymab Secures US$90 Million Funding 3Kymab Secures US$90 Million Funding 4ECUPHAR Enters the Spanish and Southern European Markets Through ESTEVE 2CBME China Launches Charity Program to Support Children with Autism 2
... 2011 Researchers from Australia have identified ... factor for Autism Spectrum Disorders.  Pink disease was common in ... illness affecting children between the ages of eighteen months and ... irritability, and progressive loss of speech, symptoms very similar to ...
... CENTENNIAL, Colo., Aug. 9, 2011 AlloSource, a ... soft-tissue allografts for use in surgical procedures around ... with the Alliance for Regenerative Medicine (ARM) and ... membership with both organizations in order to support ...
Cached Medicine Technology:Familial Susceptibility to Mercury is a Risk Factor for Autism 2AlloSource Joins Alliance for Regenerative Medicine, Medical Device Manufacturers Association 2AlloSource Joins Alliance for Regenerative Medicine, Medical Device Manufacturers Association 3
... BALLARD Adult TRACH CARE Double Swivel ... patients. Dual swivels provide flexibility without ... and tactile sleeve for better feel. ... the distance of catheter advance. Offers ...
... KIMBERLY-CLARK BALLARD Adult ... designed for endotracheal intubated ... Features clear T-Piece, lavage/irrigation ... port. Offers multiple tracheostomy ...
... Our soft, flexible whistle tip suction ... kit that includes: One pair of ... 120 ml bottle of sterile saline. ... use with cuffed gloves and catheter ...
... Irri-Cath® catheters help decrease the need ... alternative to fiber-optic bronchoscope for bronchial ... in opportunistic infections., ,All Portex® ... ,The Irri-Cath® suction system ...
Medicine Products: